All Diagnostics articles – Page 6
-
Research
Simple sensor can spot cancer markers in minutes
Test can rapidly detect mutant tumour nucleic acids in boost for personalised medicine
ResearchSilicon chip spots dangerous pathogens in human blood
Silicon wafer doped with silver nanoparticles can rapidly identify E. coli in blood
-
Research
DNA test colours in BRCA1 gene
Rolling circle amplification aids femtomolar sensitivity for gene linked with breast cancer
-
Research
Silver lining for paper Ebola test
Lateral flow test checks for Ebola, yellow fever and dengue in one go
-
Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
-
Podcast
Chemistry World podcast - November 2014
We speak to Eric Betzig about his Nobel prize-winning research, and find out how thermoelectric materials can be made more efficient
-
Feature
Faster, cheaper, better diagnostics
Microfluidics researchers are aiming to bring new diagnostic devices into mainstream medicine. Mark Peplow reports
-
Research
CPU heat powers PCR disease detection
Computer and mobile phone combo detects Chagas disease in blood and could drive down diagnosis costs
-
Research
Urine test could catch lung cancer early
Cancer diagnosis could be accelerated using an approach that is low cost, rapid and non-invasive
-
Podcast
Chemistry World podcast - September 2014
We speak to Paul Clarke about the challenges of natural product synthesis and discuss the pros and cons of perovskite solar cells
-
-
Research
Molecular computer calculates Ebola diagnosis
A prototype device displays a fluorescent ‘E’ in the presence of DNA found in Ebola virus
-
Research
Organ–organ interactions could compound nanoparticle damage
Dual-organ simulation uncovers possible toxicity mechanisms that result in liver injury
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
Business
Illumina investment push
$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
